BMEA
Biomea Fusion, Inc.NASDAQHealthcare$1.54-1.95%ClosedMarket Cap: $91.6M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.69
P/S
0.00
EV/EBITDA
-0.46
DCF Value
$0.98
FCF Yield
-78.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-243.7%
ROA
-105.5%
ROIC
-170.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-11.7M | $4.6M | $0.06 | — |
| FY 2025 | $0.00 | -Infinity% | $-81.3M | $-61.8M | $-1.18 | — |
| Q3 2025 | $0.00 | -Infinity% | $-20.8M | $-16.4M | $-0.27 | — |
| Q2 2025 | $0.00 | -Infinity% | $-21.3M | $-20.7M | $-0.51 | — |
| Q1 2025 | $0.00 | NaN% | $-29.7M | $-29.3M | $-0.80 | — |
| Q4 2024 | $0.00 | NaN% | $-30.1M | $-29.3M | $-0.81 | — |
| FY 2024 | $0.00 | NaN% | $-144.1M | $-138.4M | $-3.83 | — |
| Q3 2024 | $0.00 | NaN% | $-34.0M | $-32.8M | $-0.91 | — |
| Q2 2024 | $0.00 | NaN% | $-38.9M | $-37.3M | $-1.03 | — |
| Q1 2024 | $0.00 | NaN% | $-41.1M | $-39.1M | $-1.09 | — |
| Q4 2023 | $0.00 | NaN% | $-37.3M | $-34.9M | $-0.98 | — |
| FY 2023 | $0.00 | NaN% | $-126.1M | $-117.3M | $-3.44 | — |